Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

A federal judge recently approved Philips paying $25 million to monitor and research the affects of its major respiratory ...

Philips-exclusive DirectDigital RF samples the MR signal directly in the coil on the patient, and sends it to the reconstructor via fiber-optic cable. The result is up to 40% higher SNR ...

The Inspiration 626 was designed with compliance in mind. Multi-media patient education support materials and built-in conveniences make this efficient nebulizer system the ideal choice for ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring ...

While the progress towards FDA-cleared cuffless BP monitoring may feel lengthy, significant technological advances, regulatory modernisation, and clinical use case validation are rapidly advancing ...

Crowdfunded product Muse Ring One claims to be able to monitor blood pressure The Muse team says it's analyzed over 4,000 ...

SINGAPORE – Media OutReach Newswire – 18 October 2024 – Philips Monitors, a global leader in display technology, has announced the impactful results stemming from its ongoing Innovation Festival ...

OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure monitors with AI-powered atrial fibrillation (AFib) detection feature.

Because normative values are generally based on this site, the clinician must know on which extremity the BP monitor they are using bases its accuracy. Typically, this extremity is the upper arm.